Impact of hepatitis C in mortality in patients on hemodialysis

Cristian Paul Leon Rabanal1, Javier Cieza Zevallos, Roberto Cieza Cusato

  • 1Universidad Peruana Cayetano Heredia. cristianleonr27@hotmail.com

Insights

Hepatitis C infection did not increase mortality risk in patients undergoing hemodialysis. Survival rates were unexpectedly better for hepatitis C-infected patients compared to uninfected patients in this cohort study.

Area of Science:

  • Nephrology
  • Infectious Diseases
  • Epidemiology

Background:

  • Cardiovascular diseases are a primary cause of mortality in end-stage renal disease (ESRD) patients.
  • Viral infections, particularly hepatitis B and C, significantly impact survival and morbidity in hemodialysis patients.
  • Understanding the specific impact of hepatitis C on hemodialysis patient mortality is crucial.

Purpose of the Study:

  • To assess the influence of hepatitis C infection on the mortality rates of patients undergoing hemodialysis.
  • To investigate the relationship between hepatitis C and survival in ESRD patients on hemodialysis.

Main Methods:

  • A non-concurrent cohort study design was employed.
  • The study followed two cohorts of 74 patients each over a ten-year period.
  • Statistical analysis, including Cox-Mantel log-rank test, was used to compare survival rates.

Main Results:

  • Hepatitis C infection was not associated with an increased risk of death.
  • Patients infected with hepatitis C demonstrated better survival rates than uninfected patients.
  • One-year and five-year survival rates were 95.5% and 73.1% for hepatitis C-infected patients, versus 93.9% and 52.3% for non-infected patients (p = 0.02).

Conclusions:

  • Hepatitis C infection does not correlate with increased mortality in hemodialysis patients with ESRD.
  • The study found no increased mortality risk associated with hepatitis C in this patient population.
  • Survival outcomes were unexpectedly favorable in hepatitis C-infected hemodialysis patients.
Abstract

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
Hemodialysis III: Nursing Management01:25

Hemodialysis III: Nursing Management

The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this measurement...